Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: tonyt who wrote (14858)	2/12/1998 1:38:00 PM
From: squetch	Read Replies (2) \| Respond to of 32384

Do you think he read it? What is interesting to me is the researchers tested Tamox at 800 ug/kg. Results were 33.3%3 tumors completely regressed, 1/3 partial regression and 4.8% static. 28.6% of these Tam treated tumors continued to progress. By adding 10 mg/kg of Targretin to a dose of 150 ug/kg of Tamox they achieved 26.3% complete responses. I still wonder what the standard treatment is for Tamox alone.

To: tonyt who wrote (14858)	2/12/1998 2:45:00 PM
From: Machaon	Read Replies (2) \| Respond to of 32384

<< "It always amazes me that people can get excited about rat data since it is not really predictive of how a drug will work in humans," ... >> Are you posting this little gem because it is your view also? Hmmm!? Perhaps you shouldn't answer this note. My last post to you pointed out significant misinformation, IN DETAIL, that you have posted on the LGND thread. For obvious reasons, you dare not answer why you posted the misinformation. So...... What would be the value of reading your opinion on the use of animals for drug research? Regards, and appropriate rewards, Bob